After numerous high-profile safety scares, clinicians and regulators push to fix critical weaknesses in the FDA’s monitoring system for approved drugs.
The Scientist
Most Recent
Citizen scientists can inspire innovation and advance science education—and they are proving adept at self-policing.
How should the government ensure the safety and responsibility of do-it-yourself biologists?
Do-it-yourself science is likely as old as science itself, driven by an inherent curiosity about the world around us.
The total number of new drugs approved this year ties last year for the highest since 2004, suggesting that the pharmaceutical industry is recovering.
The US Food and Drug Administration is taking steps to get new devices on the market sooner—and antibiotics may be next.
The National Institutes of Health reveals a controversial plan to regulate the funding of H5N1 research.
A US federal court rules that procedures in which a patient's own stem cells are extracted, manipulated, and reinjected should be regulated by the FDA.
As biologic drug patents begin to expire, generic versions will hit the market—but how will they be regulated?
Science adviser John Holdren speaks out about how the Presidential Administration is handling the controversial research that rendered avian flu transmissible between ferrets.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
